Astria Therapeutics, Inc.
CIK:
0001454789
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
22 BOSTON WHARF ROAD, BOSTON, MA, 02210
Mailing Address
22 BOSTON WHARF ROAD, BOSTON, MA, 02210
Phone
617-349-1971
Fiscal Year End
1231
EIN
000000000
Financial Overview
FY2024
-$72.89M
Net Income
$23.10M
Total Liabilities
$319.26M
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | February 17, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 12, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | February 9, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | January 28, 2026 | View on SEC |
| 4 Insider stock transaction report | January 23, 2026 | View on SEC |
| 4 Insider stock transaction report | January 23, 2026 | View on SEC |
| 4 Insider stock transaction report | January 23, 2026 | View on SEC |
| 4 Insider stock transaction report | January 23, 2026 | View on SEC |
| 4 Insider stock transaction report | January 23, 2026 | View on SEC |
| 4 Insider stock transaction report | January 23, 2026 | View on SEC |
Material Events
8-K
Acquisition
January 21, 2026
High Impact
- Astria shareholders have overwhelmingly approved the acquisition by BioCryst Pharmaceuticals.
- Astria shareholders will receive immediate and substantial cash value for their shares.
8-K
Legal Issue
December 23, 2025
High Impact
- Astria Therapeutics is facing shareholder lawsuits alleging false or misleading information regarding its acquisition by BioCryst Pharmaceuticals.
- The lawsuits claim Astria and its board have not been fully transparent or accurate with merger details, potentially affecting shareholder votes.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.